Literature DB >> 28879481

Association between the number of oocytes retrieved and cumulative live birth rate in women aged 35-40 years undergoing long GnRH agonist IVF/ICSI cycles.

Jianjun Zhou1, Bin Wang1, Yali Hu1, Haixiang Sun2.   

Abstract

PURPOSE: To study the association between the numbers of oocytes retrieved and the cumulative live birth rates (LBR) in women aged 35-40 years undergoing long GnRH agonist IVF/ICSI cycles.
METHODS: A total of 931 women aged 35-40 years who underwent their first cycle of IVF/ICSI treatment between January 2010 and December 2013 at Nanjing Drum Tower Hospital were identified and reviewed. The main endpoint of this study was the cumulative LBR after one complete oocyte retrieval, which included fresh and all subsequent frozen-thaw embryo transfer cycles. Odds ratios (OR) and 95% confidence interval (CI) for live birth were estimated by multivariate logistic regression analysis. Furthermore, all the women were divided into four groups based on the number of oocytes retrieved: 0-4, 5-9, 10-14 or ≥15 oocytes group. Variables were then compared among groups.
RESULTS: We found that 634 out of the 931 patients (68.1%) achieved at least one live birth. The number of oocytes retrieved was an independent predictive factor for live birth, with OR 1.20 (95% CI 1.15-1.26) when adjusted for age (years), duration of infertility and Gn (gonadotrophin) doses. The cumulative LBR in the four different oocyte groups was 35.6, 68.8, 83.4 and 89.2%, respectively. When the 1-4 oocytes group was issued as a reference, the ORs for cumulative LBR gradually increased to 3.66, 6.74 and 11.77 in other three oocytes groups, respectively. The moderate-severe ovarian hyperstimulation syndrome (OHSS) rate was dramatically increased in the ≥15 oocytes group (6.9%) when compared to that in the 10-14 oocytes group (0.8%), while the cumulative LBR only increased 5.8% (from 83.4 to 89.2%).
CONCLUSIONS: The ideal number of oocytes retrieved in women aged 35-40 years is 10-14 oocytes, which achieves a high cumulative LBR while maintaining an acceptable low OHSS rate.

Entities:  

Keywords:  Advanced maternal age; Cumulative live birth rate; IVF; Oocyte number

Mesh:

Substances:

Year:  2017        PMID: 28879481     DOI: 10.1007/s00404-017-4503-9

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  6 in total

1.  Time to pregnancy in women with previous ectopic pregnancy undergoing in vitro fertilization treatment: a retrospective cohort study.

Authors:  Yamei Xue; Fuxing Zhang; Haocheng Zhang; Songying Zhang
Journal:  Sci Rep       Date:  2022-05-25       Impact factor: 4.996

Review 2.  Individualized controlled ovarian stimulation in expected poor-responders: an update.

Authors:  Thor Haahr; Sandro C Esteves; Peter Humaidan
Journal:  Reprod Biol Endocrinol       Date:  2018-03-09       Impact factor: 5.211

3.  Use of Cumulative Live Birth Rate per Total Number of Embryos to Calculate the Success of IVF in Consecutive IVF Cycles in Women Aged ≥35 Years.

Authors:  Meng Zhang; Tao Bu; Haiqing Tian; Xia Li; Duolao Wang; Xiaohui Wan; Qingli Wang; Xinmin Mao; Xiaolin La
Journal:  Biomed Res Int       Date:  2019-06-26       Impact factor: 3.411

4.  Human Relationships with Domestic and Other Animals: One Health, One Welfare, One Biology.

Authors:  Ariel M Tarazona; Maria C Ceballos; Donald M Broom
Journal:  Animals (Basel)       Date:  2019-12-24       Impact factor: 2.752

5.  The Optimal Number of Oocytes Retrieved From PCOS Patients Receiving IVF to Obtain Associated With Maximum Cumulative Live Birth Rate and Live Birth After Fresh Embryo Transfer.

Authors:  Rui Jia; Yuanyuan Liu; Rulan Jiang; Xuli Zhu; Liang Zhou; Peipei Chen; Mingya Cao; Zhiming Zhao
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-23       Impact factor: 6.055

6.  Causes and Effects of Oocyte Retrieval Difficulties: A Retrospective Study of 10,624 Cycles.

Authors:  Yang Wang; Meixiang Zhang; Hao Shi; Shiqi Yi; Qian Li; Yingchun Su; Yihong Guo; Linli Hu; Jing Sun; Ying-Pu Sun
Journal:  Front Endocrinol (Lausanne)       Date:  2022-01-03       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.